Mount Sinai Announces First-of-its-Kind Center For Post-COVID Care
Center to provide post-multidisciplinary care and psychosocial resources for patients recovering from pandemic disease COVID-19 Registry and clinical trials component will define new standards of care for patients
Mount Sinai Health System (MSHS) is launching a new Center for Post-COVID Care for patients recovering from the virus as they transition from hospital to home. The Center, located at Mount Sinai-Union Square, will serve as a destination for patients across MSHS and will provide comprehensive multi-specialty care and systematic evaluation of the long-term impact of COVID-19.
Although many patients with the virus experience upper airway and respiratory symptoms in the acute setting, mounting evidence suggests that these patients are also at risk for multiple systemic complications including thromboembolic disease, systemic inflammatory response syndrome, cardiovascular complications, and hepatic and renal impairment. Moreover, emerging evidence has identified striking disparities in outcomes for different patient groups, identifying older age, chronic illness, obesity, and disadvantaged socioeconomic status as important risk factors. The long-term complications of acute infection are still unknown
“Mount Sinai has been at the epicenter of the coronavirus pandemic, treating more than 8,000 patients diagnosed with COVID-19,” said Barbara Murphy, MD, Murray M. Rosenberg Professor and Chair, Department of Medicine, Icahn School of Medicine at Mount Sinai. “The entire research and clinical community has raced to understand this virus and has swiftly moved treatment and testing innovations from the lab to the bedside. The Center continues that excellence by caring for a wide spectrum of patients—from those just diagnosed to those already discharged from the hospital and those who were never hospitalized but need help recovering. Patients treated at the Center will receive comprehensive clinical care and diagnostics in collaboration with multiple medical specialties including diagnostic and supportive services.”
The Center will serve as a destination for patients across the MSHS and beyond who are seeking world-class compassionate care in state-of-the-art facilities. A personalized treatment plan will be offered to patients, using advanced diagnostic tools and innovative treatment protocols from key medical specialties including primary care, pulmonary medicine, cardiology, infectious disease, nephrology, physiatry, physical and occupational therapy, radiology, neuropsychiatry, behavioral health, social work, and pharmacy.
“Mount Sinai’s mission has always been to take care of the needs of our entire community,” said Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System. “COVID-19 will be with us for years to come, and this Center will ensure that all New Yorkers, regardless of their disease state or socioeconomic status, will be able to get the comprehensive, expert care they need for this complex disease.”
The Center will include a COVID-19 Registry, in which participating patients will undergo a baseline survey to collect information regarding sociodemographics, behaviors, comorbidities, mental health conditions, and medications. Researchers will obtain baseline measures of pulmonary symptoms, cognition and other mental health measures, and physical indicators including biometrics, spirometry, EKG, bloodwork, and antibody titers for SARS-CoV-2, the virus that causes COVID-19.
“This Center will provide a unique opportunity to follow this population and systematically evaluate the long-term impact of COVID-19,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System. “The Center will gather invaluable data to support a broad spectrum of biomedical research, including benchtop science, epidemiology, health services and outcomes, and health policy. We will rapidly translate the insights we gain through this research into better treatments for the wide spectrum of effects that SARS-CoV-2 has on the human body.”
For information about the Mount Sinai Center for Post-COVID Care, visit https://www.mountsinai.org/about/covid19/center-post-covid-care or call 212-844-6300.
Support Mount Sinai’s COVID-19 Response: Join us in this extraordinary and continuing fight against the COVID-19 pandemic and for health equity. Donate now to support our frontline clinicians who are caring for critically ill patients and our researchers who are furthering understanding of the virus, developing therapies, and addressing the wide-ranging impacts of the pandemic. Visit www.giving.mountsinai.org.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.